Molecular imaging using visible light to reveal biological changes in the brain.
Advances in imaging have enabled the study of cellular and molecular processes in the context of the living body that include cell migration patterns, location and extent of gene expression, degree of protein-protein interaction, and levels of enzyme activity. These tools, which operate over a range of scales, resolutions, and sensitivities, have opened up broad new areas of investigation where the influence of organ systems and functional circulation is intact. There are a myriad of imaging modalities available, each with its own advantages and disadvantages, depending on the specific application. Among these modalities, optical imaging techniques, including in vivo bioluminescence imaging and fluorescence imaging, use visible light to interrogate biology in the living body. Optimal imaging with these modalities require that the appropriate marker be used to tag the process of interest to make it uniquely visible using a particular imaging technology. For each optical modality, there are various labels to choose from that range from dyes that permit tissue contrast and dyes that can be activated by enzymatic activity, to gene-encoding proteins with optical signatures that can be engineered into specific biological processes. This article provides and overview of optical imaging technologies and commonly used labels, focusing on bioluminescence and fluorescence, and describes several examples of how these tools are applied to biological questions relating to the central nervous system.
Contag
Christopher H
CH
Departments of Pediatrics, Microbiology & Immunology and Radiology, E150 Clark Center, MC 5427, Stanford University School of Medicine, Stanford, CA 94305, USA. ccontag@stanford.edu
D000818:Animals; D005453:Fluorescence; D006801:Humans; D008027:Light; D008164:Luminescent Proteins; D025202:Molecular Diagnostic Techniques; D041622:Tomography, Optical; D041623:Tomography, Optical Coherence
D008164:Luminescent Proteins